Chargement en cours...
Prognostic impact of mutation profiling in patients with stage II and III colon cancer
Development of colorectal cancer (CRC) associates with accumulation of genetic mutations include the epidermal growth factor receptor (EGFR) signaling pathway. However, whether mutations in KRAS together with downstream factors BRAF, PIK3CA and NRAS impact prognosis is still unclear for stage II-III...
Enregistré dans:
| Publié dans: | Sci Rep |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830995/ https://ncbi.nlm.nih.gov/pubmed/27074743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep24310 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|